S&P 500   5,258.09 (+0.18%)
DOW   39,811.48 (+0.13%)
QQQ   443.86 (-0.22%)
AAPL   171.69 (-0.93%)
MSFT   420.48 (-0.23%)
META   487.66 (-1.26%)
GOOGL   150.98 (+0.07%)
AMZN   180.30 (+0.26%)
TSLA   176.34 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.50 (-3.64%)
AMD   180.28 (+0.38%)
BABA   72.46 (+1.22%)
T   17.63 (+0.46%)
F   13.18 (+0.92%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   174.91 (-2.89%)
DIS   122.44 (+1.21%)
AMC   3.65 (-15.90%)
PFE   27.87 (+0.32%)
PYPL   67.13 (+0.84%)
XOM   116.09 (+0.97%)
S&P 500   5,258.09 (+0.18%)
DOW   39,811.48 (+0.13%)
QQQ   443.86 (-0.22%)
AAPL   171.69 (-0.93%)
MSFT   420.48 (-0.23%)
META   487.66 (-1.26%)
GOOGL   150.98 (+0.07%)
AMZN   180.30 (+0.26%)
TSLA   176.34 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.50 (-3.64%)
AMD   180.28 (+0.38%)
BABA   72.46 (+1.22%)
T   17.63 (+0.46%)
F   13.18 (+0.92%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   174.91 (-2.89%)
DIS   122.44 (+1.21%)
AMC   3.65 (-15.90%)
PFE   27.87 (+0.32%)
PYPL   67.13 (+0.84%)
XOM   116.09 (+0.97%)
S&P 500   5,258.09 (+0.18%)
DOW   39,811.48 (+0.13%)
QQQ   443.86 (-0.22%)
AAPL   171.69 (-0.93%)
MSFT   420.48 (-0.23%)
META   487.66 (-1.26%)
GOOGL   150.98 (+0.07%)
AMZN   180.30 (+0.26%)
TSLA   176.34 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.50 (-3.64%)
AMD   180.28 (+0.38%)
BABA   72.46 (+1.22%)
T   17.63 (+0.46%)
F   13.18 (+0.92%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   174.91 (-2.89%)
DIS   122.44 (+1.21%)
AMC   3.65 (-15.90%)
PFE   27.87 (+0.32%)
PYPL   67.13 (+0.84%)
XOM   116.09 (+0.97%)
S&P 500   5,258.09 (+0.18%)
DOW   39,811.48 (+0.13%)
QQQ   443.86 (-0.22%)
AAPL   171.69 (-0.93%)
MSFT   420.48 (-0.23%)
META   487.66 (-1.26%)
GOOGL   150.98 (+0.07%)
AMZN   180.30 (+0.26%)
TSLA   176.34 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.50 (-3.64%)
AMD   180.28 (+0.38%)
BABA   72.46 (+1.22%)
T   17.63 (+0.46%)
F   13.18 (+0.92%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   174.91 (-2.89%)
DIS   122.44 (+1.21%)
AMC   3.65 (-15.90%)
PFE   27.87 (+0.32%)
PYPL   67.13 (+0.84%)
XOM   116.09 (+0.97%)
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

$72.50
-0.13 (-0.18%)
(As of 02:54 PM ET)
Today's Range
$71.91
$72.93
50-Day Range
$58.76
$75.15
52-Week Range
$55.96
$75.31
Volume
77,957 shs
Average Volume
245,473 shs
Market Capitalization
$3.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$110.00

Prestige Consumer Healthcare MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
52.2% Upside
$110.00 Price Target
Short Interest
Bearish
3.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
1.04mentions of Prestige Consumer Healthcare in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$380,296 Sold Last Quarter
Proj. Earnings Growth
6.47%
From $4.33 to $4.61 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.01 out of 5 stars

Medical Sector

217th out of 938 stocks

Pharmaceutical Preparations Industry

93rd out of 433 stocks

PBH stock logo

About Prestige Consumer Healthcare Stock (NYSE:PBH)

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

PBH Stock Price History

PBH Stock News Headlines

Prestige Consumer Healthcare Inc.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
PBH Mar 2024 55.000 put
PBH Jul 2024 70.000 call
Grab Your Free Bitcoin Today!
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot
Should You Invest in Prestige Consumer Healthcare (PBH)?
See More Headlines
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/08/2024
Today
3/28/2024
Fiscal Year End
3/31/2024
Next Earnings (Estimated)
5/02/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
CUSIP
74112D10
Employees
560
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$110.00
High Stock Price Target
$117.00
Low Stock Price Target
$103.00
Potential Upside/Downside
+51.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-82,310,000.00
Pretax Margin
-8.01%

Debt

Sales & Book Value

Annual Sales
$1.13 billion
Cash Flow
$5.06 per share
Book Value
$29.12 per share

Miscellaneous

Free Float
48,855,000
Market Cap
$3.61 billion
Optionable
Optionable
Beta
0.52
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

PBH Stock Analysis - Frequently Asked Questions

Should I buy or sell Prestige Consumer Healthcare stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PBH shares.
View PBH analyst ratings
or view top-rated stocks.

What is Prestige Consumer Healthcare's stock price target for 2024?

2 brokerages have issued 12 month price targets for Prestige Consumer Healthcare's shares. Their PBH share price targets range from $103.00 to $117.00. On average, they predict the company's share price to reach $110.00 in the next twelve months. This suggests a possible upside of 52.2% from the stock's current price.
View analysts price targets for PBH
or view top-rated stocks among Wall Street analysts.

How have PBH shares performed in 2024?

Prestige Consumer Healthcare's stock was trading at $61.22 at the beginning of 2024. Since then, PBH stock has increased by 18.0% and is now trading at $72.26.
View the best growth stocks for 2024 here
.

When is Prestige Consumer Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our PBH earnings forecast
.

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc. (NYSE:PBH) announced its earnings results on Thursday, February, 8th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.04 by $0.02. The company had revenue of $282.74 million for the quarter, compared to the consensus estimate of $280.25 million. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive trailing twelve-month return on equity of 14.09%. Prestige Consumer Healthcare's revenue was up 2.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.04 EPS.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare updated its FY 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share (EPS) guidance of 4.330-4.330 for the period, compared to the consensus EPS estimate of 4.320. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

What is Ronald M. Lombardi's approval rating as Prestige Consumer Healthcare's CEO?

8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Prestige Consumer Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.59%), Vanguard Group Inc. (11.59%), Dimensional Fund Advisors LP (6.92%), Westwood Holdings Group Inc. (2.27%), Allspring Global Investments Holdings LLC (2.10%) and Massachusetts Financial Services Co. MA (2.09%). Insiders that own company stock include Mary Beth Fritz and Ronald M Lombardi.
View institutional ownership trends
.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:PBH) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners